187 results on '"Puhl, Ana C."'
Search Results
2. The Goldilocks paradigm: comparing classical machine learning, large language models, and few-shot learning for drug discovery applications
3. Repurposing lapatinib as a triple antagonist of chemokine receptors 3, 4, and 5
4. Computational drug repositioning identifies niclosamide and tribromsalan as inhibitors of Mycobacterium tuberculosis and Mycobacterium abscessus
5. Learning from COVID-19: How drug hunters can prepare for the next pandemic
6. Multiple approaches to repurposing drugs for neuroblastoma
7. Discovery of Dual Targeting GSK-3β/HIV‑1 Reverse Transcriptase Inhibitors as Neuroprotective Antiviral Agents.
8. Machine learning-aided search for ligands of P2Y6 and other P2Y receptors.
9. Recent advances in drug repurposing using machine learning
10. Déjà vu: Stimulating open drug discovery for SARS-CoV-2
11. Sequential Contrastive and Deep Learning Models to Identify Selective Butyrylcholinesterase Inhibitors
12. Crystallographic structure and molecular dynamics simulations of the major endoglucanase from Xanthomonas campestris pv. campestris shed light on its oligosaccharide products release pattern
13. New targets for HIV drug discovery
14. Cross-species efficacy of enzyme replacement therapy for CLN1 disease in mice and sheep
15. Identification of New Modulators and Inhibitors of Palmitoyl-Protein Thioesterase 1 for CLN1 Batten Disease and Cancer
16. In silico ADME/tox comes of age: twenty years later.
17. Exploiting machine learning for end-to-end drug discovery and development
18. 1-Sulfonyl-3-amino-1H-1,2,4-triazoles as Yellow Fever Virus Inhibitors: Synthesis and Structure–Activity Relationship
19. Synthesis and Evaluation of 9-Aminoacridines with SARS-CoV-2 Antiviral Activity
20. Developing Treatments for Rare Diseases on a Shoestring
21. Repurposing the Dihydropyridine Calcium Channel Inhibitor Nicardipine as a Nav1.8 Inhibitor In Vivo for Pitt Hopkins Syndrome
22. Design of amidobenzimidazole STING receptor agonists with systemic activity
23. In silico ADME/tox comes of age: twenty years later
24. The protein disulfide isomerase inhibitor 3-methyltoxoflavin inhibits Chikungunya virus
25. Transporter Inhibition Profile for the Antivirals Tilorone, Quinacrine and Pyronaridine
26. Validation of Acetylcholinesterase Inhibition Machine Learning Models for Multiple Species
27. Developing treatments for rare diseases on a shoestring: The Batten disease (CLN1) enzyme replacement therapy experience
28. Structure and neutralization mechanism of a human antibody targeting a complex Epitope on Zika virus
29. Discovery of New Zika Protease and Polymerase Inhibitors through the Open Science Collaboration Project OpenZika
30. Machine Learning for Discovery of New ADORA Modulators
31. Discovery of PLpro and Mpro Inhibitors for SARS-CoV‑2.
32. Author Correction: Design of amidobenzimidazole STING receptor agonists with systemic activity
33. Vandetanib Blocks the Cytokine Storm in SARS-CoV-2-Infected Mice
34. Structure and Neutralization Mechanism of a Human Antibody Targeting a Complex Epitope on Zika Virus
35. Computational and Experimental Approaches Identify Beta-Blockers as Potential SARS-CoV-2 Spike Inhibitors
36. Pyronaridine Protects against SARS-CoV-2 Infection in Mouse
37. Advancing the Research and Development of Enzyme Replacement Therapies for Lysosomal Storage Diseases
38. The Need for Speed and Efficiency: A Brief Review of Small Molecule Antivirals for COVID-19
39. Discovery of a Novel Inhibitor for Chikungunya Virus
40. Efficacy of recombinant human PPT1 enzyme replacement therapy in mouse and sheep models of CLN1 disease
41. Vandetanib Reduces Inflammatory Cytokines and Ameliorates COVID-19 in Infected Mice
42. Discovery and Development of Cyclic Peptide Inhibitors of CIB1
43. Pyronaridine Protects Against SARS-CoV-2 in Mouse
44. Nanoparticulas de poli-ζ-caprolactona carregadas com hidrocortisona: preparacao usando planejamento fatorial e sua avaliacao
45. Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine: In Vitro Activity against SARS-CoV-2 and Potential Mechanisms
46. Machine Learning Models Identify Inhibitors of SARS-CoV-2
47. Development of Machine Learning Models and the Discovery of a New Antiviral Compound against Yellow Fever Virus
48. Correction to “Using Bibliometric Analysis and Machine Learning to Identify Compounds Binding to Sialidase-1”
49. Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine: In Vitro Activity against SARS-CoV-2 and Potential Mechanisms
50. Repurposing drugs for CLN1 Batten disease: An integrative drug discovery approach
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.